Effect of hormone replacement therapy on growth hormone stimulation in women with premature ovarian failure

Fertility and Sterility

Volumn 68, Issue 1, 1997, Pages 103-107

  Hartmann, Beda W ^a,b   Huber, Johannes C ^a   Kirchengast, Sylvia ^a   Söregi, Gabor ^a   Albrecht, Alexander E ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Body weight; Growth hormone; Growth hormone releasing hormone; Hormone replacement therapy; Insulin like growth factor I; Premature ovarian failure

Indexed keywords

ESTRADIOL VALERATE; FOLLITROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PROLACTIN; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GONADORELIN TEST; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OVARY INSUFFICIENCY; PRIORITY JOURNAL;

EID: 0343923421     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81483-5     Document Type: Article

References (25)

1. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51-8.
2. Merimee TJ, Rabinowitz D, Fineberg SE. Arginine initiated release of human growth hormone. N Engl J Med 1969; 26:1434-8.
3. Bennet AE, Wahner HW, Riggs BL, Hintz RL. Insulin like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab 1984;59:701-4.
4. Hartmann B, Kirchengast S, Albrecht A, Laml T, Bikas D, Huber J. Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women. Maturitas 1995;22:239-46.
5. Dawson-Huges B, Stern D, Goldmann J, Reichlin S. Regulation of growth hormone and somatomedin C secretion in postmenopausal women: effect of physiological estrogen replacement. J Clin Endocrinol Metab 1986;63:424-32.
6. Wilson DM, Dotson RJ, Neely EK, Cohen P, Hintz RL, Rosenfeld RG. Effects of estrogen on growth hormone following clonidine stimulation. Am J Dis Child 1993;147:63-5.
7. Metka M, Holzer G, Heytmanek G, Huber J. Hypergonadotropic amenorrhea (WHO III) and osteoporosis. Fertil Steril 1992;57:37-41.
8. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckmann EM. Estrogen replacement therapy. A 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 1979;53:277-86.
9. Achiron R, Levran D, Sivan E, Lipitz S, Dor J, Mashiach S. Endometrial blood flow response to hormone replacement therapy in women with premature ovarian failure: a trans-vaginal Doppler study. Fertil Steril 1995;63:550-4.
10. Karram MM, Yeko TR, Sauer MV, Bhatia NN. Urodynamic changes following hormonal replacement therapy in women with premature ovarian failure. Obstet Gynecol 1989; 74:208-11.
11. Navot D, Laufer N, Kopolovic J, Rabinovitz R, Birkenfeld A, Lewin A. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N Engl J Med 1986;314:806-11.
12. Hartman ML, Iranmanesh A, Thorner MO, Veldhuis JD. Evaluation of pulsatile patterns of growth hormone release in humans: a brief review. Am J Hum Biol 1993;5:603-14.
13. Drobney EC, Amburn K, Baumann G. Circadian variation of basal plasma growth hormone in man. J Clin Endocrinol Metab 1983;57:524-8.
14. Iranmanesh A, Lizaralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and the amplitude of growth hormone secretory bursts and the half life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991;73:1081-8.
15. Ho KKY, Weissberger AJ. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res 1992;7:821-7.
16. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
17. Shibasaki T, Shizume K, Nakahara M, Masuda A, Jibiki K, Demura H, et al. Age related changes in plasma growth hormone responses to growth hormone releasing factor in man. J Clin Endocrinol Metab 1984;58:212-7.
18. Wheatcroft NJ, Toogood AA, Li TC, Cooke ID, Weetman AP. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol 1994;96:122-8.
19. Blumenfeld Z, Halachmi S, Peretz BA, Shmuel Z, Golan D, Makler A, et al. Premature ovarian failure - the prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 1993;59:750-5.
20. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Char-acterization of idiopathic premature ovarian failure. Fertil Steril 1996;65:337-41.
21. Weissberger AJ, Ho KKY, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone secretion, insulin like growth factor I, and GH binding protein in PMP women. J Clin Endocrinol Metab 1991;72:374-81.
22. Mannor DA, Winer LM, Shaw MA, Baumann G. Plasma growth hormone (GH)-binding proteins: effect on GH binding to receptors and GH action. J Clin Endocrinol Metab 1991; 73:30-4.
23. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KK. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf) 1993;39:561-7.
24. Holly JMP, Wass JAH. Insulin like growth factors: autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J Endocrinol 1989;122:611-8.
25. Murphey LJ, Friesen HG. Differential effects of estrogen and growth hormone on uterine and hepatic insulin like growth factor I gene expression in the ovariectomized hypophysectomized rat. Endocrinology 1988;122:325-32.